Singapore

Singapore's INEX Innovate launches epiHERA® to detect Early Endometrial Cancer

Novel epiHERA® methodology optimizes sample acquisition, significantly reducing turnaround time from weeks to days, enabling equitable access to critical diagnostics ...

10x Genomics Surpasses 100 Xenium Analyzer Shipments

Rapid growth and adoption of Xenium Analyzer demonstrates strength of company's innovation engine, broad commercial reach and operational scale...

S$15 M biomedtech incubator co11ab Novena opens in Singapore

The incubator aims to advance healthcare innovations by fostering a thriving ecosystem for biomedtech startups...

Singapore builds pressure sensing technology to transform healthcare and surgical robots

An aero-elastic sensor that revolutionises the way pressure is detected...

Tan Tock Seng Hospital Partners with Thermo Fisher Scientific to Boost Precision Medicine Capabilities

First microarray-based solution in Singapore to enable multi-gene panel testing for pharmacogenomics and disease risk assessment...

Mirxes receives US FDA’s breakthrough device designation for blood-based cancer detection test

GASTROClear is the first miRNA blood test and the first gastric cancer molecular test globally to receive FDA Breakthrough Device Designation...

Singapore unveils Industry Transformation Map 2025 for healthcare

Renewing focus on primary and preventive health in medical training...

Yashoda Medicity and Draeger India Collaborate for South Asia's Largest Modular ICU Setup and Advanced Medical Gas System

Yashoda Medicity, the upcoming healthcare facility by Yashoda Foundations in Indirapuram, is collaborating with Draeger India, a renowned global medical and safety technology solutions provider. Yashoda Medicity is the new addition to the renowned healthcare institution Yashoda Super Speciality Hospital, well acknowledged for its exceptional patient care and facilities. Together, Yashoda Medicity and Dräger are embarking on a groundbreaking initiative to establish one of the largest modular Int...

East Ventures backs Aevice to bring next-gen remote respiratory platform to Southeast Asia

It is estimated that over 7% of the population in Southeast Asia suffer from Chronic Respiratory Disease with asthma and COPD amongst the most common chronic respiratory diseases...

Aevice Health's Smart Wearable Stethoscope Receives US FDA Clearance for Remote Respiratory Monitoring Platform

Aevice Health, a leading provider of remote respiratory monitoring solutions for the healthcare continuum and backed by the Cedars-Sinai Accelerator, announced that its flagship medical device, the AeviceMD, has received clearance from the U.S. Food and Drug Administration (FDA) as a Class II medical device under the 510(k) route....